A041703: A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for PH-Negative CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease
- Title
- A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for PH-Negative CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease
- Principal Investigator
- Emadi, Ashkan
- Phase
- II (Cancer Control)
- Age Group
- Adult
- Applicable Disease Sites
- Leukemia
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Abby Swiger, RN
- Research Nurse
- Phone: +1 304-293-1683
- Email: aswiger3@hsc.wvu.edu